ADAM WISOR: Open Payments
NPI 1932480167 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,967 in 161 payments from 37 companies in 2025. Trend: 2023 $2,735 · 2024 $2,930 · 2025 $2,967
Food & beverage: $2,902Education: $65
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 18 | $328 |
| ABBVIE INC. | 16 | $216 |
| Merck Sharp & Dohme LLC | 9 | $184 |
| Janssen Biotech, Inc. | 8 | $182 |
| Geron Corporation | 2 | $167 |
| GlaxoSmithKline, LLC. | 7 | $143 |
| Incyte Corporation | 11 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| PFIZER INC. | 11 | $123 |
Products named: Enhertu, KEYTRUDA, RYTELO, JAKAFI, LYNPARZA, XTANDI, ELAHERE, RYBREVANT.
Industry payments across PA — which companies pay providers there.
